Evidence map›Paper›PMID 40989513›Full record

ArticleRSC advances2025

A new multi-purpose FRET fluorescent probe for the simultaneous detection of proteases.

Petra Jedináková, Zuzana Barbuščáková, David Milićević, Martin Kubala, Jan Hlaváč

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Petra JedinákováDepartment of Organic Chemistry, Faculty of Science, Palacký University Olomouc 17. Listopadu 12 771 46 Olomouc Czech Republic jan.hlavac@upol.cz.
Zuzana BarbuščákováDepartment of Organic Chemistry, Faculty of Science, Palacký University Olomouc 17. Listopadu 12 771 46 Olomouc Czech Republic jan.hlavac@upol.cz.
David MilićevićDepartment of Organic Chemistry, Faculty of Science, Palacký University Olomouc 17. Listopadu 12 771 46 Olomouc Czech Republic jan.hlavac@upol.cz.ORCID https://orcid.org/0000-0002-8335-3068
Martin KubalaDepartment of Experimental Physics, Faculty of Science, Palacký University Olomouc 17. Listopadu 12 771 46 Olomouc Czech Republic.ORCID https://orcid.org/0000-0002-3555-0016
Jan HlaváčDepartment of Organic Chemistry, Faculty of Science, Palacký University Olomouc 17. Listopadu 12 771 46 Olomouc Czech Republic jan.hlavac@upol.cz.ORCID https://orcid.org/0000-0002-4652-7751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new methodology for the detection of three model proteases using a multi-purpose peptide probe equipped with three selectively cleavable sites and four fluorophores was developed and studied. The probe was designed as a single-excitation, triple-emission system, allowing for the monitoring of characteristic real-time changes in the fluorescence emission responses of individual fluorophores during enzymatic cleavage. It was labelled with diethylaminocoumarin (DEAC), fluorescein (FL) and Rhodamine B (RhB), forming the DEAC → FL → RhB FRET-cascade, with estimated Förster distances of 3.08 ± 0.02 nm or 3.02 ± 0.02 nm for the DEAC → FL FRET-pair (depending on the DEAC labeling site) and 6.04 ± 0.05 nm for the FL → RhB FRET-pair. Although spectroscopic analyses indicate that photophysical processes other than FRET are involved in the probe, the huge changes in its fluorescence intensities (

Identifiers

PMID40989513
PMCPMC12451675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.